{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 447983753
| IUPAC_name = ''N''-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1''H''-pyrazol-4-yl)nicotinamide
| image = nifenazone.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 2139-47-1
| ATC_prefix = M02
| ATC_suffix = AA24
| ATC_supplemental = {{ATC|N02|BB05}}
| PubChem = 4487
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1413176
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 8780F0K71U
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01437
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 4332

<!--Chemical data-->
| C=17 | H=16 | N=4 | O=2 
| molecular_weight = 308.33454 g/mol
| smiles            = c1ccccc1N2N(C)C(C)=C(C2=O)NC(=O)c3cccnc3
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C17H16N4O2/c1-12-15(19-16(22)13-7-6-10-18-11-13)17(23)21(20(12)2)14-8-4-3-5-9-14/h3-11H,1-2H3,(H,19,22)
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = BRZANEXCSZCZCI-UHFFFAOYSA-N
}}

'''Nifenazone''' is a drug that has been used as an [[analgesic]] for a number of [[rheumatic]] conditions.<ref>{{Cite journal 
| last1 = Hart | first1 = F. D. 
| last2 = Boardman | first2 = P. L. 
| title = Trial of Nifenazone ("thylin") 
| journal = British Medical Journal 
| volume = 1 
| issue = 5397 
| pages = 1553â€“1554 
| year = 1964 
| pmid = 14133613 
| pmc = 1814611
 | doi=10.1136/bmj.1.5397.1553
}}</ref>

==See also==
* [[Aminopyrine]]

==References==
{{reflist}}

{{Anti-inflammatory products}}
{{Topical products for joint and muscular pain}}

[[Category:Pyrazolones]]
[[Category:Nicotinamides]]


{{musculoskeletal-drug-stub}}